CVS HEALTH CORPORATION Revenue from Contract with Customer, Excluding Assessed Tax
CVS HEALTH CORPORATION (CVS) reported Revenue from Contract with Customer, Excluding Assessed Tax of $64.55 billion for the 3-month period ending 2019-09-30, per its 10-Q filed 2019-11-06.
Discontinued › Income Statement
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax · last filed 2019-11-06
- CVS HEALTH CORPORATION revenue from contract with customer, excluding assessed tax for the quarter ending 2019-09-30 was $64.55B, a 36.55% increase year-over-year.
- CVS HEALTH CORPORATION revenue from contract with customer, excluding assessed tax for the quarter ending 2019-06-30 was $63.14B, a 35.18% increase year-over-year.
- CVS HEALTH CORPORATION revenue from contract with customer, excluding assessed tax for the quarter ending 2019-03-31 was $61.40B, a 34.37% increase year-over-year.
- CVS HEALTH CORPORATION revenue from contract with customer, excluding assessed tax for the quarter ending 2018-12-31 was $54.25B.
| Period end | Revenue from Contract with Customer, Excluding Assessed Tax 3 month | Revenue from Contract with Customer, Excluding Assessed Tax 6 month | Revenue from Contract with Customer, Excluding Assessed Tax 9 month | Revenue from Contract with Customer, Excluding Assessed Tax 12 month |
|---|---|---|---|---|
| 2019-09-30 | $64.55B 10-Q · filed 2019-11-06 | $127.69B derived: sum of 2 quarters · filed 2019-11-06 | $189.08B 10-Q · filed 2019-11-06 | $243.33B derived: sum of 4 quarters · filed 2019-11-06 |
| 2019-06-30 | $63.14B 10-Q · filed 2019-08-07 | $124.53B 10-Q · filed 2019-08-07 | $178.78B derived: sum of 3 quarters · filed 2019-08-08 | $226.05B derived: sum of 4 quarters · filed 2019-11-06 |
| 2019-03-31 | $61.40B 10-Q · filed 2019-05-01 | $115.65B derived: sum of 2 quarters · filed 2019-08-08 | $162.91B derived: sum of 3 quarters · filed 2019-11-06 | $209.62B derived: sum of 4 quarters · filed 2019-11-06 |
| 2018-12-31 | $54.25B derived: 8-K 12 month − 10-Q 9 month · filed 2019-08-08 | $101.52B derived: sum of 2 quarters · filed 2019-11-06 | $148.23B derived: sum of 3 quarters · filed 2019-11-06 | $193.92B 8-K · filed 2019-08-08 |
| 2018-09-30 | $47.27B 10-Q · filed 2019-11-06 | $93.98B derived: sum of 2 quarters · filed 2019-11-06 | $139.67B 10-Q · filed 2019-11-06 | |
| 2018-06-30 | $46.71B 10-Q · filed 2019-08-07 | $92.40B 10-Q · filed 2019-08-07 | ||
| 2018-03-31 | $45.69B 10-Q · filed 2019-05-01 | |||
| 2017-12-31 | $184.76B 8-K · filed 2019-08-08 | |||
| 2016-12-31 | $177.53B 8-K · filed 2019-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PETMED EXPRESS INC (PETS) | United States | $0.034B | -1.41 |